Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Investors
Contact

Menu

Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Investors
Contact

Search

Close

中文

Menu

中文

Our Vision

Home > Company > Our Vision

Our Vision
Company Profile
Management Team
Journey & Honors

Menu

Our Vision
Company Profile
Management Team
Journey & Honors

We are committed to leading the development of new drugs for the treatment of genitourinary tumors and other major diseases

Links

Company
Technology
Pipeline
Collaboration
News
Careers
Contact

News

Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance
Asieris Included in the SSE STAR Biology and Medicine Index
Highlights of Asieris 2022 Semi-Annual Report
Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy
Asieris on Science and Technology Innovation Board “2022 Most Innovative Companies” List
Now Hiring: Business Development Director (Remote)
Now Hiring: Biomarker Scientist (Onsite, Mountain View)

Contact

info@asieris.com
USA
201 King of Prussia Rd.
Suite 650 Radnor, PA 19087
USA
319 N. Bernardo Ave.
Mountain View, CA 94043
China
8F Building 56
1000 Jinhai Rd
Pudong, Shanghai

Join Us

Partner with us

Copyright © 2014-2022 Asieris Pharmaceuticals. All Rights Reserved.